Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin’s lymphoma to many other types of solid cancers
Article in Oncotarget (September 2020)
The most recent citing publications are shown below. View all 40 publications that cite this research output on Dimensions.
Immunopeptidome screening to design An immunogenic construct against PRAME positive breast cancer; An in silico study
Article in Computational Biology and Chemistry (February 2020)
Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targets
Article in Vaccine (May 2019)